Literature DB >> 8698056

Relationship between thallium-201 uptake by supratentorial glioblastomas and their morphological characteristics on magnetic resonance imaging.

M Ricci1, P Pantano, A Pierallini, D Di Stefano, A Santoro, L Bozzao, G L Lenzi.   

Abstract

Single-photon emission tomography (SPET) with thallium-201 is used in the assessment of patients with gliomas because the amount of 201Tl accumulated by the tumoral cells increases in proportion to the degree of tumour malignancy, thus making it possible to differentiate high-grade from low-grade gliomas or recurrences from radiation necrosis. However, in large areas of tissue such as those examined in 201Tl SPET studies, the uptake of 201Tl may vary considerably even in tumours with the same histological diagnosis, as occurs in glioblastomas (GBMs). In order to evaluate the possible influence of the macroscopic characteristics of tumours on 201Tl uptake, we studied a series of 13 patients with histologically proven GBMs, comparing magnetic resonance imaging (MRI) parameters such as tumour dimensions, perilesional oedema, intratumoral necrosis and contrast enhancement with the degree of 201Tl uptake. The patients underwent both 201Tl SPET and MRI before surgery. The 201Tl index (tumour/contralateral unaffected brain) was calculated using two different region of interest (ROI) methods: the first employed irregular large ROIs (3.2+/-13.9 cm2) including pixels with more than 50% maximum activity; the second employed regular square small ROIs (2.7 cm2) centered on the maximum activity of the lesion. Of the MRI morphological parameters studied, only necrosis significantly reduced the degree of 201Tl uptake in GBMs when larger ROIs were used. However, by using small regular ROIs the influence of necrosis on 201Tl uptake was found to be less relevant. Since necrosis is related to tumour proliferative activity and represents a negative prognostic factor in astrocytoma, a possible underestimation of 201Tl uptake due to intratumoral necrosis must be carefully evaluated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8698056     DOI: 10.1007/bf00833386

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  34 in total

1.  Thallium-201 SPECT imaging of brain tumors: methods and results.

Authors:  K T Kim; K L Black; D Marciano; J C Mazziotta; B H Guze; S Grafton; R A Hawkins; D P Becker
Journal:  J Nucl Med       Date:  1990-06       Impact factor: 10.057

2.  Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas.

Authors:  M C Chamberlain; J A Murovic; V A Levin
Journal:  Neurology       Date:  1988-09       Impact factor: 9.910

Review 3.  The new WHO classification of brain tumours.

Authors:  P Kleihues; P C Burger; B W Scheithauer
Journal:  Brain Pathol       Date:  1993-07       Impact factor: 6.508

4.  Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients.

Authors:  J J Kepes
Journal:  Ann Neurol       Date:  1993-01       Impact factor: 10.422

5.  Thallium-201 SPECT for predicting histological types of meningiomas.

Authors:  S Jinnouchi; H Hoshi; T Ohnishi; S Futami; S Nagamachi; K Watanabe; T Ueda; S Wakisaka
Journal:  J Nucl Med       Date:  1993-12       Impact factor: 10.057

6.  Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain tumors: a within-subject comparison.

Authors:  L A O'Tuama; S T Treves; J N Larar; A B Packard; A J Kwan; P D Barnes; R M Scott; P M Black; J R Madsen; L C Goumnerova
Journal:  J Nucl Med       Date:  1993-07       Impact factor: 10.057

7.  Thallium-201 brain tumor imaging: a comparative study with pathologic correlation.

Authors:  W D Kaplan; T Takvorian; J H Morris; C L Rumbaugh; B T Connolly; H L Atkins
Journal:  J Nucl Med       Date:  1987-01       Impact factor: 10.057

8.  Biodistributions of 201Tl in tumor bearing animals and inflammatory lesion induced animals.

Authors:  A Ando; I Ando; M Katayama; S Sanada; T Hiraki; H Mori; N Tonami; K Hisada
Journal:  Eur J Nucl Med       Date:  1987

9.  Contribution of thallium-201-SPECT to the grading of tumorous alterations of the brain.

Authors:  R Burkard; K P Kaiser; H Wieler; P Klawki; A Linkamp; L Mittelbach; T Göller
Journal:  Neurosurg Rev       Date:  1992       Impact factor: 3.042

10.  The evaluation of contrast-enhancing brain lesions: pitfalls in current practice.

Authors:  M Piszczor; G Thornton; F J Bia
Journal:  Yale J Biol Med       Date:  1985 Jan-Feb
View more
  1 in total

1.  201Thallium SPECT and 1H-MRS compared with MRI in chemotherapy monitoring of high-grade malignant astrocytomas.

Authors:  K Kallén; I M Burtscher; S Holtås; E Ryding; I Rosén
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.